Anakinra has also been effective in treatment of human patients with Schnitzler syndrome (an autoimmune disorder) or with mutations in cold-induced autoinflammatory syndrome 1 gene (CIAS1) [57]. Here, NLRP3 is linked to Schnitzler syndrome.